Investment Outlook for the Oligonucleotide Synthesis Market

https://www.marketsandmarkets.....com/Market-Reports/o

The global oligonucleotide synthesis market is projected to reach USD 19.7 billion by 2029 from USD 8.8 billion in 2024, at a CAGR of 17.5% during the forecast period. The major factors driving the growth of this market are the increasing adoption of oligonucleotides in therapeutics for the treatment of many neurological and rare diseases, ongoing funding and investments provided by the government and major players for life science and synthetic biology research and growing awareness about alternate therapies for various diseases.

Navigating Growth: Opportunities and Challenges in Healthcare Analytical Testing Services

https://www.marketsandmarkets.....com/Market-Reports/h

The Healthcare analytical testing services Market is projected to reach a valuation of USD 7.4 billion in 2024, with an anticipated surge to USD 12.6 billion by 2029, exhibiting a CAGR of 11.2% throughout the forecast period. Growth in the Healthcare analytical testing services Market is mainly driven by factors such as Growing pharmaceutical and biopharmaceutical R & D activities, stringent regulatory requirements, rising number of clinical trials, growing focus on biosimilars and biologics and rising acceptance of QbD approach in pharma research and manufacturing. However, lack of skilled professionals and rising costs and market competition can negatively affect growth of the market during the forecast period.

The prominent players in the global healthcare analytical testing services market include Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), Element Materials Technology (UK), Thermo Fisher Scientific, Inc. (US), Pace Analytical Services LLC (US), Intertek Group plc (UK), IQVIA Inc. (US), Merck KGaA (Germany), Source BioScience (UK), Almac Group (UK), ICON Plc (Ireland), Frontage Laboratories, Inc. (US), STERIS Plc (US), Sartorius AG (Germany), ALS Life Science (US), Syneos Health, INC (US), Medpace Holdings, Inc. (US), LGC Limited (UK), Parexel International Corporation (US), Celerion (US). Pharmaron (China), and BioAgilytix Labs (US).

Evolving Technologies: The Role of Oral Appliances in Managing Sleep Apnea

https://www.marketsandmarkets.....com/Market-Reports/s

The global sleep apnea oral appliances market is expected to reach USD 0.9 billion by 2028 from USD 0.4 billion in 2023, at a CAGR of 15.2% during the forecast period. Factors such as the increasing prevalence of sleep apnea, growing awareness and diagnosis of sleep apnea, and advancement in oral appliance technology are expected to drive the demand for sleep apnea oral appliances market. According to the National Council on Aging, approximately 39 million in US suffer from obstructive sleep apnea (OSA).

The sleep apnea oral appliances market is competitive and is dominated by various players. The major players operating in this market are SomnoMed (Australia), ResMed (US), Whole You, Inc. (US), ProSomnus Sleep Technologies (US), and Vivos Therapeutic, Inc. (US). These include a range of initiatives such as introducing new products, establishing contracts and partnerships, pursuing mergers and acquisitions, and engaging in new product development endeavors. These actions aim to enhance their position in the market for sleep apnea oral appliances.

Exploring the Endoscopy Equipment Market: Innovations and Advancements

https://www.marketsandmarkets.....com/Market-Reports/e

The global endoscopy equipment market is projected to reach USD 46.2 billion by 2029 from USD 32.3 billion in 2024, at a CAGR of 7.4%. Endoscopy is a minimally-invasive method that uses specialised equipment to observe interior organs or tissues. These operations use a variety of tools, including scopes designed for specific procedures, anaesthetic apparatus, video screens, lighting devices, imaging technology, monitoring equipment, storage cabinets, video processors, insufflators, and carts. They are used by medical specialists such as gastroenterologists, cardiologists, nephrologists, neurologists, hepatologists, and gynaecologists to perform safe examinations and interventions.

Companion Diagnostics: Pioneering Pathways to Targeted Therapies

https://www.marketsandmarkets.....com/Market-Reports/c

The global companion diagnostics market is projected to reach USD 13.6 billion by 2029 from USD 7.5 billion in 2024, at a CAGR of 12.6%